Re:How India's Patent Office Destroyed Gilead's Global Game ...
by throwawaykf05 on Friday January 16, 2015 @06:11AM
(#8898185)
Not very sure what they mean exactly, but the FDA mandates clinical trials, right? Can that data not be used to show increased efficacy, if any?
Re:How India's Patent Office Destroyed Gilead's Global Game ...
by striking on Friday January 16, 2015 @09:24AM
(#8899030)
FDA trials are only required to compete against a placebo. A drug is accepted if it is safe and more effective than a placebo in a double-blind clinical trial. That's it.
So they have no data to show with, unless they went above and beyond to get it. (Which should teach them a lesson about testing their drugs.)
Re:How India's Patent Office Destroyed Gilead's Global Game ...
by refurb on Friday January 16, 2015 @10:53AM
(#8899622)
You don't have to have head-to-head data to claim your drug is superior to existing therapies. Yes, head-to-head data is the best way to show it, but if you have two separate trials, each comparing to a placebo, you can draw conclusions about relative efficacy. It's not perfect, but in the case of Gilead, their drug blows away anything else currently on the market.
But the Patent Office says that "efficacy" here means therapeutic efficacy, and it would need to be proven by a clinical trial.